نتایج جستجو برای: j bms db

تعداد نتایج: 304413  

Journal: :The lancet. HIV 2015
Jacob P Lalezari Gulam H Latiff Cynthia Brinson Juan Echevarría Sandra Treviño-Pérez Johannes R Bogner Melanie Thompson Jan Fourie Otto A Sussmann Pena Fernando C Mendo Urbina Marcelo Martins Iulian G Diaconescu David A Stock Samit R Joshi George J Hanna Max Lataillade

BACKGROUND BMS-663068 is an oral prodrug of BMS-626529, an attachment inhibitor that binds to HIV-1 gp120, blocking viral attachment to host CD4 cells. AI438011 is an ongoing trial investigating the efficacy, safety, and dose-response of BMS-663068 in treatment-experienced, HIV-1-infected patients. Herein we present the results of the primary analysis. METHODS AI438011 is a phase 2b, randomis...

Journal: :Antimicrobial agents and chemotherapy 2002
Philippe Cottagnoud Fernando Acosta Marianne Cottagnoud Marc Pfister Martin G Täuber

BMS 284756 penetrated well into inflamed meninges (44% +/- 11%) and produced good bactericidal activity (-0.82 +/- 0.22 Delta log(10) CFU/ml. h) in the treatment of experimental meningitis in rabbits due to a penicillin-sensitive strain. BMS 284756 monotherapy had a greater potency than the standard regimen of ceftriaxone and vancomycin (-0.49 +/- 0.08 Delta log(10) CFU/ml. h) against a penicil...

Journal: :Mathematical Structures in Computer Science 2008
Jan A. Bergstra Kees Middelburg

Maurer computers for pipelined instruction processing† J. A. BERGSTRA‡ and C. A. MIDDELBURG§ ‡Programming Research Group, University of Amsterdam, P.O. Box 41882, 1009 DB Amsterdam, the Netherlands and Department of Philosophy, Utrecht University, P.O. Box 80126, 3508 TC Utrecht, the Netherlands Email: [email protected] §Programming Research Group, University of Amsterdam, P.O. Box 41882, 100...

Journal: :Current Controlled Trials in Cardiovascular Medicine 2005
Ulrich Dietz Cheryl Dauer Heinz Lambertz

BACKGROUND Stent length serves as a predictor of restenosis in use of bare metal stents (BMS). This has been demonstrated in a feasibility study that used a single short BMS implant (<9 mm) in a high proportion of lesions; the study observed a low rate of restenosis. METHODS We performed a pilot prospective study to investigate in a series of consecutive patients the immediate and long-term e...

2015
Cibele Nasri-Heir Julyana Gomes Zagury Davis Thomas Sowmya Ananthan

Burning mouth syndrome (BMS) is a chronic pain condition. It has been described by the International Headache Society as "an intra-oral burning or dysesthetic sensation, recurring daily for more than 2 h/day for more than 3 months, without clinically evident causative lesions." BMS is frequently seen in women in the peri-menopausal and menopausal age group in an average female/male ratio of 7:1...

Journal: :Public health nutrition 2007
Rhona J McInnes Charlotte Wright Shogufta Haq Margaret McGranachan

OBJECTIVE To evaluate compliance with the World Health Organization's International Code of Marketing of Breast-milk Substitutes in primary care, after the introduction of strict local infant feeding guidelines. DESIGN An audit form was sent to all community-based health professionals with an infant feeding remit. Walking tours were conducted in a random sample of community care facilities. ...

Journal: :The Journal of pharmacology and experimental therapeutics 2002
Gary J Grover Albert J D'Alonzo Raymond B Darbenzio Charles S Parham Thomas A Hess Mohinder S Bathala

Recent studies have shown the importance of mitochondrial ATP-sensitive potassium channels (K(ATP)) in cardioprotection, and studies in vitro have shown that the benzopyran analog (3R)-trans- 4-((4-chlorophenyl)-N-(1H-imidazol-2-ylmethyl)dimethyl-2H-1-benzopyran-6-carbonitril monohydrochloride (BMS-191095) is a selective mitochondrial K(ATP) opener with cardioprotective activity. The goal of th...

Journal: :The American journal of cardiology 2008
Jiro Aoki Ajay J Kirtane George D Dangas Alexandra J Lansky Andy Morales Masashi Kimura Young-Hak Kim Issam Moussa Giora Weisz Edward M Kreps Michael Collins Theresa Frankin-Bond Gregg W Stone Jeffrey W Moses Martin B Leon Roxana Mehran

When it is difficult to deliver multiple drug-eluting stents (DES) or when size constraints limit DES implantation, bare-metal stents (BMS) may be implanted contiguous to DES. However, the clinical outcomes after overlapping DES and BMS implantation are not known. From September 2004 to June 2006, 4,872 consecutive patients who underwent percutaneous coronary intervention consented to be enroll...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2006
Mayer N Fishman Christopher R Garrett George R Simon Alberto A Chiappori Richard M Lush William R Dinwoodie J Joseph Mahany Anne M Dellaportas Alan Cantor Ashwin Gollerki Marvin B Cohen Daniel M Sullivan

RATIONALE BMS-188797 is one of several novel taxanes in ongoing clinical development. It has superior activity in experimental tumor models when compared with paclitaxel. BMS-188797 has a single C-4 modification, a 4-desacetyl-4-methylcarbonate, compared with paclitaxel. METHODS We did a phase I study, in which a fixed dose of carboplatin was combined with a dose escalation schedule of BMS-18...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید